By David McAfee (January 25, 2013, 10:12 PM EST) -- Citing a lack of jurisdiction, a Pennsylvania federal judge on Friday dismissed AstraZeneca PLC from a False Claims Act whistleblower suit brought by a former Medco Health Solutions Inc. pharmacist who claims AstraZeneca gave Medco $60 million in kickbacks to increase the market share of ulcer drugs Prilosec and Nexium.
U.S. District Judge J. William Ditter Jr.'s order dismissing claims against AstraZeneca mirrors his October 2010 order clearing Bristol-Meyers Squibb Co. of identical charges, finding in both cases that relator Karl Schumann lacked standing to bring the actions because all allegations had been publicly disclosed in other civil actions and in...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!